Boston Scientific's $14.5 Billion Penumbra Deal Reshapes the MedTech Landscape
Boston Scientific agrees to acquire Penumbra for $14.5 billion in the largest MedTech deal in two decades, signaling that healthcare M&A remains robust despite high rates.